Call Us Today: 1-877-SHEIN-LAW (1-877-743-4652)

← Older posts Newer posts →

Chemical Exposure Risks in Chester, Pennsylvania  

Residents of Chester, Pennsylvania have been the victims of pollution-related health risks for decades. Chester is home to numerous hazardous and municipal waste treatment sites, which generate air pollution and can contaminate soil and groundwater. Now members of the community are taking matters into their own hands, starting environmental watchdog groups and holding meetings to

» Read More...
Posted on

New Proton Therapy Facility in South Jersey

A revolutionary new type of cancer treatment will soon be available in South Jersey. A $35 million state-of-the-art proton facility, which will debut in 2020, will be built on the campus of Virtua’s acute care hospital at Virtua Voorhees. Penn Medicine is building the facility in partnership with Virtua. The new proton therapy center –

» Read More...
Posted on

Dental Technicians at Risk of Asbestos Exposure

Many people who are diagnosed with mesothelioma contract the disease after exposure to asbestos in the workplace. Workers in industries such as construction are known to have a higher than normal risk of asbestos exposure, but the danger may also be lurking in some unexpected places. A recent study in Italy revealed that dental technicians

» Read More...
Posted on

OSHA Regulations for Silica Dust

The U.S. Occupational Safety and Health Administration (OSHA) establishes safety standards to protect workers from hazards on the job. While these standards are important to attempt to decrease workplace injuries or illnesses, implementing them can sometimes be difficult for companies. The regulations may be expensive or impractical to put in place, or companies may have

» Read More...
Posted on

New Leadership at Penn Medicine’s Abramson Cancer Center

The Abramson Cancer Center (ACC) at Penn Medicine recently named Dr. Robert Vonderheide as its next director. He succeeded Dr. Chi Van Dang, who held the position since 2011. Vonderheide is internationally recognized for his work in cancer immunotherapy and translational research. He joined the ACC in 2001 after receiving a Ph.D. in immunology and

» Read More...
Posted on

Shein Law Sponsors 2017 Philly Fights Cancer, Round 3 Fundraising Event

The Star-Studded Gala Raised $7 Million to Fight Cancer For more than 30 years, Shein Law has successfully represented the victims of occupationally caused cancers and their families. We have seen firsthand the suffering caused by illnesses that never should have happened. That is why Shein Law has joined the fight against cancer as a

» Read More...
Posted on

Biomarker Could Help Diagnose Mesothelioma

Researchers in Switzerland are hopeful about a new diagnostic tool for malignant pleural mesothelioma. The interaction between a surface molecule found on cancer cells and a particular protein may signal the presence of the disease, and can even help to distinguish it from other cancers. This biomarker could help foster a timely mesothelioma diagnosis without

» Read More...
Posted on

Immunotherapy Shows Promise

Exceedingly rare and aggressive, mesothelioma is a form of cancer that takes root in the lining of the lungs, heart, or abdomen, in response to asbestos exposure.  Patients have a survival rate of less than one year after learning they have mesothelioma, which has no known cure.  In recent years, certain individuals with mesothelioma participating

» Read More...
Posted on

Government-Funded Cancer Research

This year, the annual meeting of the American Society of Clinical Oncology (ASCO) – the world’s largest gathering of cancer researchers – will present significantly fewer studies that are fully funded by the National Institutes of Health (NIH). That’s a dramatic decrease for American researchers, who usually dominate the meeting’s news conferences, which typically present

» Read More...
Posted on

South Jersey Asbestos Lawyers Discuss New Diagnostic Tool for Mesothelioma

A biomarker in lung fluid may hold the key to early diagnosis of mesothelioma. Mesothelioma, a rare and deadly form of cancer infecting the lining of the lungs and chest cavity, often mimics other respiratory conditions and is difficult to diagnose. However, a research team from Italy has found that testing for the biomarker soluble

» Read More...
Posted on